top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Japan's Olympus names Stefan Kaufmann as next CEO in medtech pivot

gdelacruz57
Oct 26, 2022
1 min read

Tokyo, October 21. 2022 (Reuters) -- Olympus Corp (7733.T) said on Friday that Stefan Kaufmann would become the endoscope maker's chief executive next year, becoming one of the few foreigners to run a major Japanese company.

Read full article here.

Recent Posts

Azalea Therapeutics launches with $82M to pioneer in vivo precision genomic medicines

Berkeley, CA, November 4, 2025 (Globe Newswire) -- Azalea Therapeutics has launched with $82 million in seed and Series A funding led by Third Rock Ventures to advance its Enveloped Delivery Vehicle

BrainScope Appoints Matt Adams as CEO to Drive Next Phase of AI-Powered Brain Health Innovation

Rockville, MD, November 4, 2025 (Business Wire) -- BrainScope announced the appointment of Matt Adams as Chief Executive Officer, succeeding Laurie Silver, who becomes President and continues guidi

Braveheart launches with $185M to advance heart drug rivaling Bristol Myers’ therapy

Delaware, November 5, 2025 (finance yahoo) -- Braveheart Bio has emerged from stealth with $185 million in Series A funding to advance BHB-1893, a potential best-in-class treatment for hypertrophic

Comments

Life Science Headlines

Azalea Therapeutics launches with $82M to pioneer in vivo precision genomic medicines

BrainScope Appoints Matt Adams as CEO to Drive Next Phase of AI-Powered Brain Health Innovation

Braveheart launches with $185M to advance heart drug rivaling Bristol Myers’ therapy

Recursion Announces CEO Transition to Propel Next Growth Phase

Thermo Fisher Scientific to Acquire Clario Holdings for $8.9B to Deepen Clinical Insights and Accelerate Drug Development

Boston Scientific to Acquire Nalu Medical for $533M, Expanding Its Chronic Pain Treatment Portfolio

Valitor Appoints Ophthalmic and Biotech Veteran Gregory D. Kunst as CEO

BioCryst to Acquire Astria for $920M, Expanding HAE Portfolio

EchoNous Appoints Tony Titus as New CEO, Bringing 25 Years of MedTech Leadership

Blackstone and TPG to Acquire Hologic in $18.3B Deal

bottom of page